You are here

daclizumab

Biogen, AbbVie drug slows MS episodes, safety issues recur

Yahoo/Reuters

Mon, 06/16/14 - 08:35 pm

multiple sclerosis

Biogen, AbbVie drug slows MS episodes, safety issues recur

Yahoo/Reuters

Mon, 06/16/14 - 10:17 am

multiple sclerosis

Here's Why Biogen Could Be in Store for a Big 2014

Motley Fool

Wed, 02/12/14 - 06:48 pm

Biogen Hits Primary Endpoints in MS Study

Motley Fool

Sat, 04/6/13 - 10:53 am

multiple sclerosis

Biogen Idec up after positive MS drug study

Marketwatch

Thu, 04/4/13 - 01:54 pm

multiple sclerosis

Abbott Labs: Genes Aren't The Only Thing That Can Effectively Be Spliced

Seeking Alpha

Wed, 10/26/11 - 09:06 am

Abbott Laboratories

Abbott, Biogen Idec say multiple sclerosis drug achieved study goal of decreasing relapse

Yahoo/AP

Mon, 10/24/11 - 11:00 am

Abbott Laboratories

multiple sclerosis

Encouraging Data on Daclizumab

Yahoo/Zacks

Sat, 08/13/11 - 02:25 pm

Abbott Laboratories

multiple sclerosis

Biogen Starts Patient Enrollment

Yahoo/Zacks.com

Wed, 05/26/10 - 11:11 am

Abbott Laboratories

Acorda Therapeutics

Abbott a Step Closer to FACT

Yahoo/Zacks

Sat, 04/10/10 - 12:10 pm

Abbott Laboratories

multiple sclerosis

Why Biogen Idec Is Likely to Flinch Before Facet Biotech in Their Game of Chicken

BNET Pharma

Tue, 10/27/09 - 08:24 am